(4R-CIS)-1,1-DIMETHYLETHYL-6-[2-[2-(4-FLUOROPHENYL)-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO) CARBONYL]-1H-PYRROL-1-yl]ETHYL]-2,2-DIMETHYL-1,3-DIOXANE-4-ACETATE CAS:125971-95-1

The structural complexity of (4R-CIS)-1,1-Dimethylethyl-6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate presents a myriad of opportunities for pharmacological exploration and therapeutic innovation. The combination of the fluorophenyl, pyrrole, and phenylamino carbonyl groups within the dioxane ring framework offers a platform for designing molecules with diverse biological activities and potential clinical applications. In drug discovery and development, researchers can investigate the pharmacological properties of this compound by exploring its interactions with biological targets, such as receptors, enzymes, or signaling pathways. The presence of the fluorophenyl and pyrrole moieties suggests potential binding affinity to specific protein targets, which could modulate cellular responses or biochemical pathways associated with various diseases. Moreover, the phenylamino carbonyl group adds further structural versatility, allowing for potential modifications to enhance drug-like properties, such as solubility, stability, and bioavailability. Through medicinal chemistry studies and in vitro/in vivo evaluations, scientists can elucidate the pharmacokinetic profiles and therapeutic potentials of (4R-CIS)-1,1-Dimethylethyl-6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate and derivatives thereof. By synthesizing analogs or structurally related compounds based on this scaffold, researchers can tailor molecules with optimized pharmacological activities for specific disease indications, such as cancer, inflammation, or neurological disorders. The intricate design of (4R-CIS)-1,1-Dimethylethyl-6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate opens avenues for innovative drug development strategies and precision medicine approaches. In conclusion, this compound represents a compelling candidate in medicinal chemistry research, offering a wealth of possibilities for creating novel pharmaceutical agents with targeted therapeutic effects and enhanced therapeutic benefits. Its intricate molecular architecture and potential biological activities underscore its significance in advancing drug discovery initiatives and addressing unmet medical needs in healthcare.